Home › NDC Lookup › Ingredients › Ascorbic Acid, Cholecalciferol, Thiamine... › 72835-0660-01
Matervia ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium citrate, iron, iodine 125 mg; 20 ug; 1.4 mg; 5-PHOSPHATE 2.5 mg; 1000 ug; 1000 ug; 200 mg; 13 mg; 150 ug Capsule, 60-count — NDC 72835-0660-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Matervia ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium citrate, iron, iodine 125 mg; 20 ug; 1.4 mg; 5-PHOSPHATE 2.5 mg; 1000 ug; 1000 ug; 200 mg; 13 mg; 150 ug Capsule, 60-count — NDC 72835-660-01 (Billing 72835-0660-01)

by V2 Pharma LLC · 60 CAPSULE in 1 BOTTLE

This is a package of 60 capsules of Matervia ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium citrate, iron, iodine 125 mg; 20 ug; 1.4 mg; 5-PHOSPHATE 2.5 mg; 1000 ug; 1000 ug; 200 mg; 13 mg; 150 ug Capsule from V2 Pharma LLC, marketed since Jun 2025 and currently FDA-listed. It is this product's only package size.

NDC 72835-0660-01
🏷️ FDA NDC (as labeled) 72835-660-01 billing pads the product segment with a zero
Rx only On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 72835-660-01 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
72835 labeler · 660 product · 01 package
Package marketed since
Jun 11, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
60 EA per package
Barcode (UPC)
0372835660019
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 72835-660-01
Product NDC 72835-660
11-digit billing NDC 72835066001
NCPDP billing unit EA — each (per item)
UNII PQ6CK8PD0R, 1C6V77QF41, 8K0I04919X, F06SGE49M6, 935E97BOY8, BR1SN1JS2W +3 more
UPC 0372835660019
SPL Set ID a918e273-4742-4417-8ae5-88d3870011f0
Established class (EPC) Vitamin C; Vitamin D
Chemical class Ascorbic Acid; Vitamin D
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-06-11
Route ORAL
Dosage form CAPSULE
Substance ASCORBIC ACID; CHOLECALCIFEROL; THIAMINE MONONITRATE; PYRIDOXAL 5-PHOSPHATE; FOLIC ACID; METHYLCOBALAMIN; CALCIUM CITRATE; IRON; POTASSIUM IODIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 088037
GCN 58116
HICL code 050752
Ingredient (HICL) Pnv No.178/Iron Bg/Folic Acid
HIC1 code E
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition (C Cont)
HIC2 code E0
Therapeutic class — intermediate (HIC2) Vitamins (C6 Continued)
HIC3 code E0G
Therapeutic class — specific (HIC3) Prenatal Vitamins With Low Or No Iron
AHFS code 20:04.04.00
AHFS class Iron Preparations
FDB label name MATERVIA PRENATAL CAPSULE
FDB brand name Matervia
Legend status Q — Non-drug — dietary supplement, vitamin, medical food, or herbal preparation
Quick answers
  • GSN (GCN sequence number): 088037
  • GCN: 58116
  • HICL (First Databank): 050752
  • AHFS class code: 20:04.04.00
Why two NDCs? The FDA registers this code as 72835-660-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 72835-0660-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name MATERVIA PRENATAL CAPSULE Ingredient Pnv No.178/Iron Bg/Folic Acid
🧪 What is this product?

Matervia is an oral capsule containing a combination of vitamins and minerals, including vitamin C (ascorbic acid), vitamin D (cholecalciferol), B vitamins (thiamine, pyridoxal-5-phosphate, folic acid, and methylcobalamin), and minerals such as calcium, iron, and iodine. These ingredients are typically used together in nutritional supplement formulations to support general vitamin and mineral intake. This product is marketed without an approved FDA application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
72835-0660-01 You're viewing this Main listing 60 CAPSULE in 1 BOTTLE 2025-06-11 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Matervia 125 mg/1; 20 ug/1; 1.4 mg/1; 5-PHOSPHATE 2.5 mg/1; 1000 ug/1; 1000 ug/1; 200 mg/1; 13 mg/1; 150 ugthis 72835-0660-01 V2 60 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jun 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color white
Shapecapsule
Size23 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3NXW29V3WO
    Hypromellose is a plant-based thickener made from cellulose. It's used in medicines as a binder to hold ingredients together, a coating for tablets, and a thickener for liquids.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.

2 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerV2 Pharma LLC
Labeler code72835
First marketedJun 2025
Product typeHuman Prescription Drug
Portfolio9 products on file

More NDCs from V2 Pharma LLC labeler code 72835

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
⏱️ Dosage and Administration ⚠️ Warnings 📦 How Supplied / Storage and Handling 📄 Package Label / Principal Display Panel
⏱️ Dosage and Administration 20 words ▾

DOSAGE & ADMINISTRATION Suggested use is 2 capsules taken orally once daily or as prescribed by a licensed medical practitioner.

⚠️ Warnings 135 words ▾

WARNING AND PRECAUTIONS WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

CONTRAINDICATIONS: Matervia is contraindicated in patients with a known hypersensitivity to any of the ingredients. Do not take this product if you are presently taking mineral oil, unless directed by a doctor. PRECAUTION: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B is deficient.

Folic acid in doses above 1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. Matervia should only be used under the direction and supervision of a licensed medical practitioner.

📦 How Supplied / Storage and Handling 99 words ▾

HOW SUPPLIED HEALTH CLAIM: Matervia Capsules are available in 60-count bottles NDC 72835-660-01 Dispensed by Prescription† † This product is a prescription-folate with or without other dietary ingredients that – due to increased folate levels increased risk associated with masking of B12 deficiency (pernicious anemia) requires administration under the care of a licensed medical practitioner (61 FR 8760). This product may be administered only under a physician’s supervision and all prescriptions using this product shall be pursuant to state statutes as applicable.

The ingredients, indication or claims of this product are not to be construed to be drug claims.

📄 Package Label / Principal Display Panel 14 words ▾

PACKAGE LABEL Matervia NDC 72835-660-01 The label for Matervia is shown below: Matervia Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by V2 Pharma LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
V2 Pharma LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 72835-0602-02 · V2 72835-0701-02 · V2 →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.